Clinical Trials · NCT07285629
Safety and Efficacy of Klotho and Follistatin Gene Therapy
- Phase
- EARLY_Phase 1
- Recruitment status
- Completed
- Sponsor
- Minicircle
- Enrollment
- 14
- Start date
- Dec 2025
- Locations
- 2 sites, United States, Honduras
- Primary endpoint
- Concentration of Serum α-Klotho Measured by Enzyme-Linked Immunosorbent Assay (ELISA) (pg/mL)